Ontario man Alex Shved, who has Stage 4 melanoma, challenged OHIP after it denied funding for TIL therapy in Florida costing about US$600,000. A court ordered the province to reconsider his request. OHIP later rejected it again, while Ontario changed regulations governing out-of-country drug funding, limiting when patients can receive public coverage abroad.
Ontario man Alex Shved, who has Stage 4 melanoma, challenged OHIP after it denied funding for TIL therapy in Florida costing about US$600,000. A court ordered the province to reconsider his request. OHIP later rejected it again, while Ontario changed regulations governing out-of-country drug funding, limiting when patients can receive public coverage abroad.
<iframe src="https://hindustansphere.com/embed/cluster/75ad794a346503bf2b60eb9b988dc7806319caad" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Ontario man wins OHIP battle for US cancer therapy"></iframe>
